Join KBI Biopharma, Inc. at CPhI Japan! Be sure to stop by our booth to meet with Toshihiro Ogawa, Senior Director of Business Development.
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
CPHI Japan is the ideal business platform for international pharma professionals to join in order to grow their business in the rapidly evolving Japanese pharma market. The year 2023 marks a significant milestone for CPHI Japan so you can be sure to expect an event full of festivities!